CMS seeks comments on patient experience data

To drive the collection and availability of performance data on the fledgling Physician Compare consumer website, the Centers for Medicare & Medicaid Services (CMS) is seeking provider feedback about the use of patient experience measures.

In a request for comment scheduled for publication in the Dec. 7 Federal Register, CMS invites physicians to share their thoughts on the pros and cons of collecting such data.

CMS is required by the healthcare reform law to develop and implement a plan for publicly reporting physician performance data by Jan. 1, 2013. One of the provisions of the reform law mandates the inclusion of patient experience data on the CMS' Physician Compare website.

According to the request for comment, the Consumer Assessment of Healthcare Providers and Systems survey for Physician Quality Reporting, a tool used to gauge patient experience in physician practices, "will fulfill this requirement."

Physician Compare's predecessor, Hospital Compare, included metrics of patient experience such as patient-reported impressions of pain management, communication with nurses and hospital cleanliness using data from the Hospital Consumer Assessment of Healthcare Providers and Systems survey. Physician Compare will be populated by much of the data from CMS' Physician Quality Reporting System, a voluntary program launched in 2007 that provides physicians with incentive payments for reporting performance data.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.